Clinical Trial Update: A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s) [Phase 4]

View source ↗

Summary

Phase 4 study assessing the efficacy and safety of Synvisc (hylan G-F 20) injections in Chinese patients with symptomatic knee osteoarthritis. The trial is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Osteoarthritis of the Knee

Drugs mentioned

• Synvisc (Hylan G-F 20)

Snippet

Sponsor: Sanofi | Conditions: Osteoarthritis | Phase 4 | Status: COMPLETED | Results posted: 2016-02-24